InnovHeart (Newton, Massachusetts and Milan) announced the first trans-septal clinical trial implant of its proprietary Saturn transcatheter mitral valve. According to the company, there were excellent hemodynamic results for the patient — a 79-year-old woman suffering from severe mixed (degenerative and functional) mitral regurgitation. The procedure was part of system’s ongoing European clinical trial, the […]
innovheart
InnovHeart appoints former J&J executive as CEO
InnovHeart this week announced that it appointed medtech veteran David Wilson as CEO. Wilson has more than 30 years of experience in medical device industry. He previously served in numerous leadership roles at Johnson & Johnson, including worldwide president of Cordis. Wilson has also served at J&J as president of Mentor, VP of Ethicon R&D […]
FDA names Flatiron Health’s Abernethy as deputy commish | Personnel Moves, December 19, 2018
The FDA this week named Amy Abernethy, the chief medical officer for Roche subsidiary Flatiron Health, as principal deputy commissioner to replace Rachel Sherman, who is retiring in January. “She’s a highly regarded thought leader who has held numerous positions of leadership in her fields of interest and distinguished herself for her intellect, her passion […]
Medtronic taps former JP Morgan analyst Weinstein for strategy SVP | Personnel Moves – May 7, 2018
Medtronic (NYSE:MDT) said today it tapped former J.P. Morgan Chase & Co. analyst Mike Weinstein as its strategy senior VP. Prior to joining Medtronic, Weinstein served as a managing director for JP Morgan’s equity research healthcare team, holding positions within the unit for more than 20 years, the Fridley, Minn.-based company said. “We are excited to […]
